Literature DB >> 21567400

Stromal cell-derived factor-1/CXC receptor 4 and β1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells.

Wen-Shih Huang1, Chih-Chien Chin, Cheng-Nan Chen, Yi-Hung Kuo, Te-Chuan Chen, Hong-Ren Yu, Shui-Yi Tung, Chien-Heng Shen, Yung-Yu Hsieh, Su-Er Guo, Chung-Sheng Shi, Ta-Ju Liu, Hsing-Chun Kuo.   

Abstract

The stromal cell-derived factor-1 (SDF-1)/CXC receptor 4 (CXCR4) axis has been shown to play a role in colorectal cancer progression. In addition, the protease urokinase-type plasminogen activator (uPA) is an important factor in tumor cell invasion and metastasis. However, the mechanism by which SDF-1 mediates uPA expression in human colorectal cancer cells remains unknown. We investigated the molecular mechanism governing the interaction between SDF-1 stimulation and uPA expression in three human colon cancer cell lines (DLD-1, SW48, and COLO 205). We found that SDF-1 stimulation led to an increase in the expression and secretion of uPA in these cells. Experiments involving specific inhibitors and small interfering RNA demonstrated that the activation of p38 mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)/Akt pathways are critical for SDF-1-induced uPA expression. Analysis of transcription factor binding using ELISA and chromatin immunoprecipitation assays revealed that SDF-1 increased Sp1- and AP-1-DNA-binding activities in DLD-1 cells. Inhibition of Sp1 and AP-1 activation blocked the SDF-1-induced expression and activity of the uPA promoter. The effect of SDF-1 on DLD-1 signaling and uPA expression was mediated by the CXCR4/β1 integrin axis. In summary, our findings elucidate the mechanisms of SDF-1/CXCR4 downstream signaling and provide insights into the function of SDF-1 in colon cancer cells.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21567400     DOI: 10.1002/jcp.22831

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  14 in total

Review 1.  Concise review: The obesity cancer paradigm: exploration of the interactions and crosstalk with adipose stem cells.

Authors:  Amy L Strong; Matthew E Burow; Jeffrey M Gimble; Bruce A Bunnell
Journal:  Stem Cells       Date:  2015-02       Impact factor: 6.277

Review 2.  β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.

Authors:  Boju Pan; Junchao Guo; Quan Liao; Yupei Zhao
Journal:  Oncol Lett       Date:  2018-02-16       Impact factor: 2.967

3.  HIF-1α and HSP90: target molecules selected from a tumorigenic papillary thyroid carcinoma cell line.

Authors:  Ji-Hun Mo; Ik J Choi; Woo-Jin Jeong; Eun-Hui Jeon; Soon-Hyun Ahn
Journal:  Cancer Sci       Date:  2012-01-09       Impact factor: 6.716

4.  Anticancer effects of sweet potato protein on human colorectal cancer cells.

Authors:  Peng-Gao Li; Tai-Hua Mu; Le Deng
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

5.  Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells.

Authors:  Yung-Yu Hsieh; Chien-Heng Shen; Wen-Shih Huang; Chih-Chien Chin; Yi-Hung Kuo; Meng Chiao Hsieh; Hong-Ren Yu; Te-Sheng Chang; Tseng-Hsi Lin; Yung-Wei Chiu; Cheng-Nan Chen; Hsing-Chun Kuo; Shui-Yi Tung
Journal:  J Biomed Sci       Date:  2014-06-14       Impact factor: 8.410

6.  Upregulation of TLRs and IL-6 as a marker in human colorectal cancer.

Authors:  Chien-Chang Lu; Hsing-Chun Kuo; Feng-Sheng Wang; Ming-Huey Jou; Ko-Chao Lee; Jiin-Haur Chuang
Journal:  Int J Mol Sci       Date:  2014-12-24       Impact factor: 5.923

7.  CXC chemokine ligand 12/stromal cell-derived factor-1 regulates cell adhesion in human colon cancer cells by induction of intercellular adhesion molecule-1.

Authors:  Shui-Yi Tung; Shun-Fu Chang; Ming-Hui Chou; Wen-Shih Huang; Yung-Yu Hsieh; Chien-Heng Shen; Hsing-Chun Kuo; Cheng-Nan Chen
Journal:  J Biomed Sci       Date:  2012-10-25       Impact factor: 8.410

8.  Terminalia catappa attenuates urokinase-type plasminogen activator expression through Erk pathways in Hepatocellular carcinoma.

Authors:  Chao-Bin Yeh; Yung-Luen Yu; Chiao-Wen Lin; Hui-Ling Chiou; Ming-Ju Hsieh; Shun-Fa Yang
Journal:  BMC Complement Altern Med       Date:  2014-04-30       Impact factor: 3.659

9.  The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells.

Authors:  Wen-Shih Huang; Meng-Chiao Hsieh; Cheng-Yi Huang; Yi-Hung Kuo; Shui-Yi Tung; Chien-Heng Shen; Yung-Yu Hsieh; Chih-Chuan Teng; Kam-Fai Lee; Te-Chuan Chen; Ko-Chao Lee; Hsing-Chun Kuo
Journal:  PLoS One       Date:  2016-09-26       Impact factor: 3.240

10.  Effect of AICAR and 5-Fluorouracil on X-ray Repair, Cross-Complementing Group 1 Expression, and Consequent Cytotoxicity Regulation in Human HCT-116 Colorectal Cancer Cells.

Authors:  Ko-Chao Lee; Chien-Tsong Lin; Shun-Fu Chang; Cheng-Nan Chen; Jing-Lan Liu; Wen-Shih Huang
Journal:  Int J Mol Sci       Date:  2017-11-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.